The estimated Net Worth of Thomas Samuel Mc Clenahan is at least $3.68 Milion dollars as of 2 January 2022. Mr Clenahan owns over 2,000 units of Masimo Corp stock worth over $2,919,952 and over the last 12 years he sold MASI stock worth over $0. In addition, he makes $757,634 as Exec. VP i Gen. Counsel & Corp. Sec. at Masimo Corp.
Mr has made over 23 trades of the Masimo Corp stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 2,000 units of MASI stock worth $228,380 on 2 January 2022.
The largest trade he's ever made was exercising 22,000 units of Masimo Corp stock on 31 August 2015 worth over $465,960. On average, Mr trades about 4,392 units every 63 days since 2013. As of 2 January 2022 he still owns at least 25,571 units of Masimo Corp stock.
You can see the complete history of Mr Clenahan stock trades at the bottom of the page.
Thomas Samuel McClenahan is the Exec. VP, Gen. Counsel & Corp. Sec. at Masimo Corp.
As the Exec. VP i Gen. Counsel & Corp. Sec. of Masimo Corp, the total compensation of Mr McClenahan at Masimo Corp is $757,634. There are 11 executives at Masimo Corp getting paid more, with Joseph Kiani having the highest compensation of $14,996,100.
Mr McClenahan is 48, he's been the Exec. VP i Gen. Counsel & Corp. Sec. of Masimo Corp since . There are 16 older and 8 younger executives at Masimo Corp. The oldest executive at Masimo Corp is Thomas Harkin, 80, who is the Independent Director.
Thomas's mailing address filed with the SEC is C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE, CA, 92618.
Over the last 17 years, insiders at Masimo Corp have traded over $198,004,099 worth of Masimo Corp stock and bought 212,683 units worth $10,354,127 . The most active insiders traders include Joe E Kiani, Edward L Cahill oraz Yongsam Lee. On average, Masimo Corp executives and independent directors trade stock every 14 days with the average trade being worth of $2,669,077. The most recent stock trade was executed by Joe E Kiani on 8 August 2024, trading 231,748 units of MASI stock currently worth $8,769,344.
masimo (nasdaq: masi) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. our work is making a measurable difference in the world by saving, extending and improving the lives of people of all ages, in all walks of life for more than 27 years, our innovative medical technologies and noninvasive patient monitoring solutions have been solving ‘unsolvable’ problems. the result is a portfolio of clinically-proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making. masimo is for‘what-ifers’, ‘never-say-never-ers’, and ‘world changers’—people who look beyond what others see. we're looking for people who can, do, and will make a difference. we think you'll like what you see.
Masimo Corp executives and other stock owners filed with the SEC include: